
Tamoxifen Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 10 mg and 20 mg
Reference Brands: Nolvadex(US & EU)
Category: Oncology Cancer Care
Tamoxifen is available in Tablets and strengths such as 10 mg and 20 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Tamoxifen is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.
Technical Specifications & Supply Details | |
---|---|
Lead Time | 7 to 60 days (depending on batch size & schedule) |
MOQ | As per manufacturer’s batch size |
COA | Available with every batch |
Regulatory Dossier / DMF | Available upon request |
Export Documentation | FSC, COA, Manufacturing License, Product Permission |
Standards | IP, BP, USP |
Certifications | WHO-GMP, EU-GMP, USFDA (as applicable) |
Tamoxifen can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Product Description: Tamoxifen is a widely used oncology drug for breast cancer treatment and prevention, primarily available as oral tablets in 10 mg and 20 mg strengths in the U.S. and EU. Under the brand name Nolvadex, Tamoxifen is a selective estrogen receptor modulator (SERM), effective in treating estrogen receptor-positive (ER+) breast cancer by blocking estrogen’s growth-promoting effects. It is available in both U.S. and EU markets with generic alternatives. Tamoxifen plays a critical role in adjuvant therapy and breast cancer prevention for high-risk patients. Its availability in oral form makes it suitable for B2B pharmaceutical distribution.
Frequently Asked Questions
Related Products
Atezolizumab
Strength: 1200 mg/20 mL
Form: Intravenous infusion
Reference Brands: Tecentriq® (EU & US)
View DetailsDurvalumab
Strength: 120 mg/4 mL, 500 mg/10 mL
Form: Injection
Reference Brands: Imfinzi® (US & EU)
View DetailsSunitinib
Strength: 12.5 mg, 25 mg, 37.5 mg, 50 mg
Form: Tablet
Reference Brands: Sutent® (EU & US)
View DetailsQuick Response Guaranteed | Verified Suppliers